371 related articles for article (PubMed ID: 34773725)
21. A 1064-nm Neodymium-doped Yttrium Aluminum Garnet Picosecond Laser for the Treatment of Hyperpigmented Scars.
Koren A; Niv R; Cohen S; Artzi O
Dermatol Surg; 2019 May; 45(5):725-729. PubMed ID: 30882504
[TBL] [Abstract][Full Text] [Related]
22. Neodymium-doped yttrium aluminium garnet (Nd:YAG) 1064-nm picosecond laser vs. Nd:YAG 1064-nm nanosecond laser in tattoo removal: a randomized controlled single-blind clinical trial.
Pinto F; Große-Büning S; Karsai S; Weiß C; Bäumler W; Hammes S; Felcht M; Raulin C
Br J Dermatol; 2017 Feb; 176(2):457-464. PubMed ID: 27518129
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of an epidermal growth factor-containing cream on postinflammatory hyperpigmentation after 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser treatment of acquired bilateral nevus of Ota-like macules (Hori's nevus) in Asians: A split-face, double-blinded, randomized controlled study.
Wattanakrai P; Sindhusen S; Ploydaeng M
J Cosmet Dermatol; 2022 May; 21(5):2031-2037. PubMed ID: 35066982
[TBL] [Abstract][Full Text] [Related]
24. Split lesion randomized comparative study between long pulsed Nd:YAG laser 532 and 1,064 nm in treatment of facial port-wine stain.
Al-Dhalimi MA; Al-Janabi MH
Lasers Surg Med; 2016 Nov; 48(9):852-858. PubMed ID: 27669109
[TBL] [Abstract][Full Text] [Related]
25. In vivo trial comparing patients' tolerance of Q-switched Alexandrite (QS Alex) and Q-switched neodymium:yttrium-aluminum-garnet (QS Nd:YAG) lasers in the treatment of nevus of Ota.
Chan HH; King WW; Chan ES; Mok CO; Ho WS; Van Krevel C; Lau WY
Lasers Surg Med; 1999; 24(1):24-8. PubMed ID: 10037348
[TBL] [Abstract][Full Text] [Related]
26. A Split-Face, Single-Blinded, Randomized Controlled Comparison of 532 nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser versus 532 nm Q-Switched Neodymium-Doped Yttrium Aluminum Garnet Laser in the Treatment of Solar Lentigines.
Kim JY; Yang J; Huh G; Choi YJ; Kim WS
Ann Dermatol; 2020 Feb; 32(1):8-13. PubMed ID: 33911703
[TBL] [Abstract][Full Text] [Related]
27. A split-face study: comparison of picosecond alexandrite laser and Q-switched Nd:YAG laser in the treatment of melasma in Asians.
Lee MC; Lin YF; Hu S; Huang YL; Chang SL; Cheng CY; Chang CS
Lasers Med Sci; 2018 Nov; 33(8):1733-1738. PubMed ID: 29732522
[TBL] [Abstract][Full Text] [Related]
28. Using a Low Fluence Q-Switched 532/1064-nm Nd: YAG Laser for Facial Skin Depigmentation in Asian Patients: Outcome and Complication Profile Analysis.
Shen JH; Chang CC; Chen YT; Hsih CJ; Huang H; Lin BS
Ann Plast Surg; 2016 Feb; 77 Suppl 1():S32-5. PubMed ID: 27404474
[TBL] [Abstract][Full Text] [Related]
29. Split-face comparison of the picosecond 1064-nm Nd:YAG laser using a microlens array and the quasi-long-pulsed 1064-nm Nd:YAG laser for treatment of photoaging facial wrinkles and pores in Asians.
Yim S; Lee YH; Choi YJ; Kim WS
Lasers Med Sci; 2020 Jun; 35(4):949-956. PubMed ID: 31734761
[TBL] [Abstract][Full Text] [Related]
30. Treatment of idiopathic onychodystrophy with a 1064 nm picosecond neodymium-doped:yttrium aluminum garnet laser: A retrospective study.
Lee YH; Lee HJ; Kim WS; Lee GY; Choi YJ
J Cosmet Dermatol; 2021 Feb; 20(2):497-505. PubMed ID: 32593217
[TBL] [Abstract][Full Text] [Related]
31. A low-fluence 1064-nm Q-switched neodymium-doped yttrium aluminium garnet laser for the treatment of café-au-lait macules.
Kim HR; Ha JM; Park MS; Lee Y; Seo YJ; Kim CD; Lee JH; Im M
J Am Acad Dermatol; 2015 Sep; 73(3):477-83. PubMed ID: 26169691
[TBL] [Abstract][Full Text] [Related]
32. Q-switched double frequency Nd:YAG 532-nm nanosecond laser vs. double frequency Nd:YAG 532-nm picosecond laser for the treatment of solar lentigines in Asians.
Vachiramon V; Iamsumang W; Triyangkulsri K
Lasers Med Sci; 2018 Dec; 33(9):1941-1947. PubMed ID: 29948457
[TBL] [Abstract][Full Text] [Related]
33. High-fluence 1064-nm Q-Switched Nd:YAG laser: Safe and effective treatment of café-au-lait macules in Asian patients.
Baek JO; Park IJ; Lee KR; Ryu HR; Kim J; Lee S; Kim YR; Hur H
J Cosmet Dermatol; 2018 Jun; 17(3):380-384. PubMed ID: 29726114
[TBL] [Abstract][Full Text] [Related]
34. Treatment of Melasma and Post-Inflammatory Hyperpigmentation by a Picosecond 755-nm Alexandrite Laser in Asian Patients.
Lee YJ; Shin HJ; Noh TK; Choi KH; Chang SE
Ann Dermatol; 2017 Dec; 29(6):779-781. PubMed ID: 29200769
[TBL] [Abstract][Full Text] [Related]
35. Clinical Outcome of 1064-nm Picosecond Neodymium-Doped Yttrium Aluminium Garnet Laser for the Treatment of Hypertrophic Scars.
Choi YJ; Kim JY; Nam JH; Lee GY; Kim WS
J Cosmet Laser Ther; 2019; 21(2):91-98. PubMed ID: 29757022
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of a novel picosecond laser using combination of 1 064 and 595 nm on patients with melasma: A prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial.
Choi YJ; Nam JH; Kim JY; Min JH; Park KY; Ko EJ; Kim BJ; Kim WS
Lasers Surg Med; 2017 Dec; 49(10):899-907. PubMed ID: 28906574
[TBL] [Abstract][Full Text] [Related]
37. Low-fluence Q-switched 1,064-nm neodymium-doped yttrium aluminum garnet laser for the treatment of facial partial unilateral lentiginosis in Koreans.
Lee Y; Choi EH; Lee SW
Dermatol Surg; 2012 Jan; 38(1):31-7. PubMed ID: 22093176
[TBL] [Abstract][Full Text] [Related]
38. New application of the long-pulsed Nd-YAG laser as an ablative resurfacing tool for skin rejuvenation: a 7-year study.
Alshami MA
J Cosmet Dermatol; 2013 Sep; 12(3):170-8. PubMed ID: 23992158
[TBL] [Abstract][Full Text] [Related]
39. Treatment of melasma with a low-fluence 1064 nm Q-switched Nd:YAG laser: Laser toning in Caucasian women.
Micek I; Pawlaczyk M; Kroma A; Seraszek-Jaros A; Urbańska M; Gornowicz-Porowska J
Lasers Surg Med; 2022 Mar; 54(3):366-373. PubMed ID: 34473361
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and Safety of Q-switched Double-frequency 532-nm Neodymium-doped Yttrium Aluminum Garnet Laser in the Treatment of Lip Hyperpigmentation: A Pilot Study.
Al-Haddab M; Alali A; Al-Otiabi H
J Clin Aesthet Dermatol; 2021 Jul; 14(7):22-25. PubMed ID: 34840645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
